Expert Witness Directory Your Expert Witness

Your Expert Witness Forensic Healthcare Services
Your Expert Witness Manderstam International Group

Our partners: acheter cialis paris, achats priligy pas cher, priligy en france

Our partnerships: essay writing service uk, buy college essays online, coursework help


Last update01:44:19 PM GMT

Medico Legal

South American implants manufacturer has CE Mark suspended

On 25 September the Medicines & Healthcare products Regulatory Agency (MHRA) announced it had temporarily suspended the use of South American manufacturer Silimed's silicone implants in the UK after its CE Mark had been suspended following an inspection by a German notified body.

In a statement the MHRA said: "The German medical device regulatory authority informed MHRA on Friday 18 September 2015 that a German notified body had temporarily suspended the marketing and distribution of all medical devices manufactured by Silimed.

"A recent inspection of the manufacturing facility by the notified body identified particles on the surface of some devices.

Last Updated on Wednesday, 07 October 2015 13:56


Scandals continue over NHS trusts as findings are published

There appears to be a never-ending succession of scandals involving NHS trusts. It began with the Mid Staffs affair, which stunned the nation and led to a traumatic inquiry. Meanwhile, in the North West another scandal was unfolding at Furness General Hospital in Barrow.

The inquiry into the University Hospitals of Morecambe Bay NHS Trust, the trust in charge at Barrow, has now concluded and its findings published - just as the largest NHS trust in England, Barts Health NHS Trust, has been rated 'Inadequate' by the Chief Inspector of Hospitals, Professor Sir Mike Richards, following a Care Quality Commission (CQC) report.

Even mental health provision is falling foul of the CQC inspectors, with the BBC reporting on continuing problems at Norfolk and Suffolk NHS Foundation Trust. The trust was the first in the mental health sector to be placed into special measures, also following a rating of 'Inadequate'.

Things are improving there since the measures were introduced in February, it seems, but slowly.

Last Updated on Tuesday, 16 June 2015 13:20


Plastic surgeons call for better informed press reporting

Despite a rise of almost 8,000% in reporting of cosmetic surgery in the mainstream media over the past 20 years, many products and techniques promoted directly to the press and public actually have very few, if any, published scientific articles behind them, according to research presented to the Annual Scientific Meeting of the British Association of Aesthetic Plastic Surgeons (BAAPS) in September.

The study looked into some of the most popular treatments and found not only that clinical papers on them are scarce, but also that those studies that did take place followed very low numbers of cases (one trial just tracked two patients), usually for a very short amount of time. Moreover, well over a third of the authors involved admitted to conflicts of interest. The BAAPS called for the media and public to use a measuring system similar to those used in surgical journals which 'grades' the levels of evidence behind new procedures and claims.

Last Updated on Friday, 20 February 2015 10:13


Francis Review seeks the views of those on the front line

Sir Robert Francis QC has been seeking the views of health workers and associated agencies who have had experiences - both good and bad - of raising concerns in the NHS.

The consultation, which ran until 10 September, formed part of the review Freedom and Responsibility to Speak Up: An Independent Review into Creating an Open & Honest Reporting Culture in the NHS.

The review was set up as part of a package of measures announced in June to consider what further action is necessary to protect NHS workers who speak out in the public interest and help to create the kind of open culture that is needed to ensure safe care for patients.

Last Updated on Thursday, 19 February 2015 17:10


Health experts encouraged by initial primary school flu pilot results

Initial results of the uptake and impact of the child flu vaccine pilot programme launched last year by Public Health England (PHE) are encouraging, according to an article published in Eurosurveillance.

In 2012 the Joint Committee on Vaccination and Immunisation advised extending the national flu immunisation programme to all children from the age of two to less than 17 years. In addition to protecting healthy children from flu, the extension aimed to reduce the spread of flu and protect younger siblings, grandparents and those who are at increased risk of becoming seriously ill from flu.

As a first step in the extension of the programme, last year all children aged two and three years were offered flu vaccination, while children aged between four and 11 years were vaccinated in seven pilot areas in England in 2013/14. A total of 104,792 primary age children received at least one dose of a nasal spray flu vaccine or a needle vaccine for the small number of children unable to receive the nasal spray vaccine. That represented an overall uptake of 52.5% in the target group.

Last Updated on Sunday, 22 June 2014 20:00